SOM News: SomnoMed posts record Q4 and delivers on FY22 revenue guidance - 27th Jul 2022, 5:45am

[annb0t]

PLANO, Texas, July 26, 2022 /PRNewswire/ -- SomnoMed Limited (ASX "SOM", or the Company), a leading company in the provision of oral appliance treatment solutions for sleep-related breathing disorders and obstructive sleep apnea ('OSA'), is pleased to provide its quarterly activities report for the period ended 30 June 2022 (Q4 FY22). SomnoMed® is the world’s largest supplier of oral sleep apnea devices, operating in 28 countries.

SomnoMed posts record Q4 and delivers on FY22 revenue gu...

>>> Read more: SomnoMed posts record Q4 and delivers on FY22 revenue guidance